Work

Preferentially Expressed Antigen of Melanoma (PRAME)-Specific Cytotoxic T-Lymphocytes (CTLs) and Transgenic T Cells To Target Chronic Myelogenous Leukemia (CML).

Year: 2007

Type: article

Source: Blood

DOI: 10.1182/blood.v110.11.2761.2761

Authors: C. Quintarelli, G. Dotti, B. De Angelis, V. Hoyos, M. Mims, F. Pane, Helen E. Heslop, C.M. Rooney, M.K. Brenner, B. Savoldo

Institution: Baylor College of Medicine

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2979299109

FWCI:

Cites:

Cited by:

Related to: 10